Granules pharmaceuticals stock
Web1 day ago · On Wednesday, the BSE Healthcare index was the top sectoral performer. It rose 2.2% to its highest level in three months to close at 22,883.08. In comparison, benchmark indices posted marginal gains to extend the rally for the eight straight sessions. The Sensex closed at 60,392.77, up 235.05 points, or 0.39%, from the previous close. WebJan 24, 2024 · ANI. Published On Jan 24, 2024 at 05:45 PM IST. Hyderabad (Telangana): Granules India announced on Tuesday that the US Food and Drug Administration (US FDA) has approved the abbreviated new drug ...
Granules pharmaceuticals stock
Did you know?
WebJan 19, 2024 · We can see from the most recent balance sheet that Granules India had liabilities of ₹20.2b falling due within a year, and liabilities of ₹2.42b due beyond that. Offsetting this, it had ₹5.60b in cash and ₹8.53b in receivables that were due within 12 months. So its liabilities total ₹8.47b more than the combination of its cash and ... WebJul 21, 2024 · Hyderabad, July 21, 2024: Granules India Limited announced that Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary of the Company located in Chantilly, Virginia, USA had undergone a Pre- Approval Inspection (PAI) audit by the U.S. Food and Drug Administration (FDA) from 21 st June 2024 to 25 th June 2024. The audit …
WebApr 5, 2024 · The Company sells its products in the global markets, including United States of America, Canada, Latin America, Europe, Asia Pacific and India. Its wholly owned subsidiaries include Granules USA Inc, Granules Pharmaceuticals Inc, Granules Europe Limited and Granules Lifesciences Private Limited. WebMar 21, 2024 · The packaging facility in Manassas is spread over 79,000 sq ft and has several packaging suites to service customer needs, the pharmaceutical company …
WebApr 11, 2024 · 532482 Stock Overview. Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. About the company WebGet the latest Granules India Ltd (GRANULES) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
WebSep 3, 2024 · Sep 3, 2024. Granules Pharmaceuticals Inc., the North American subsidiary of an Indian drug manufacturer, is growing in Northern Virginia again. The company has signed a lease for 79,000 square ...
WebJan 28, 2024 · View 12 reports from 6 analysts offering long term price targets for Granules India Ltd.. Granules India Ltd. has an average target of 375.83. The consensus estimate represents an upside of 25.53% from the last price of 299.40. Reco - This broker has downgraded this stock from it's previous report. chinese homer nyWebMar 28, 2024 · granules pharmaceuticals Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. granules pharmaceuticals Blogs, Comments and Archive News on Economictimes.com ... Stock market update: Nifty Pharma index advances 0.31% in an upbeat market. The Nifty Pharma index was trading 0.31 per cent … grand national car priceWebJan 29, 2024 · See 12 recent research reports for GRANULES, BSE:532482 Granules India Ltd. from 6 source(s) with an average share price target of 376. Markets Today Top Gainers ADANIGREEN 4.33%. ATGL 3.63%. Top Losers CHOLAFIN -0.89%. PGHH -0.59%. Discover: Search filings ... grand national buick carWebMay 17, 2024 · About Granules India Ltd. (BSE: 532482) and (NSE: GRANULES) Granules India is a growing pharmaceutical manufacturing company with best in class facilities and is committed to operational ... chinese honey chicken near meWebJul 27, 2024 · Granules Pharmaceutical Inc. (GPI), Chantilly, VA, a wholly owned subsidiary of Granules India Limited, would like to clarify that there has been no … chinese honey chickenWebThe Granules India PE ratio based on its reported earnings over the past 12 months is 11.45.The shares last closed at IN₹285.45.. The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. chinese honey barbecue chickenWebInformation on stock, financials, earnings, subsidiaries, investors, and executives for Granules India. Use the PitchBook Platform to explore the full profile. ... Granules Biocause Pharmaceuticals: 06-Mar-2007: Joint Venture: Drug Discovery: To view Granules India’s complete investments and acquisitions history, request access » chinese home style tofu